ConductScience.org, home

Paper30003574

Concordance of PD-L1 expression in matched urothelial bladder cancer specimens.

de Jong JJ and 4 others. Histopathology, 2018. Cited by 28 papers, by iCite.

Cite this record

ConductScience Library. Concordance of PD-L1 expression in matched urothelial bladder cancer specimens. Papers, record 30003574. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/30003574

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Concordance of PD-L1 expression in matched urothelial bladder cancer specimens.
PubMed
Journal
Histopathology
PubMed
Year
2018
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
28
iCite
Relative citation ratio, by iCite
0.99
iCite
Revised in PubMed
2019-03-07
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1de Jong JJJoep J
2Stoop HHans
3Nieboer DDaan
4Boormans JLJoost L
5van Leenders GJLHGeert J L Hhttps://orcid.org/0000-0003-2176-9102

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
B7-H1 AntigenMajor topic
Carcinoma, Transitional CellMajor topic
Urinary Bladder NeoplasmsMajor topic
Aged
Cystectomy
Female
Humans
Immunohistochemistry
Lymphatic Metastasis
Male
Middle Aged
Urinary Bladder

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
RochePubMed

Source PubMed

Download CSV of grants

Cited by17

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 28 citations.

PMIDTitleJournalYearIn PapersSource
42755500Case Report: Radical nephroureterectomy after toripalimab plus disitamab vedotin in biomarker-non-enriched upper tract urothelial carcinoma.Front Oncol2026https://conductscience.org/library/papers/42755500PubMed
42729159Disease stage-dependent expression of ADC-related biomarkers in urothelial carcinoma.Transl Androl Urol2026https://conductscience.org/library/papers/42729159PubMed
39280671Are primary tumors suitable for biomarker-guided treatment of metastatic urothelial cancer?Transl Androl Urol2024https://conductscience.org/library/papers/39280671PubMed
39186130[German expert consensus on programmed cell death ligand 1 (PD-L1) testing in perioperative systemic therapy of muscle invasive bladder cancer].Urologie2024https://conductscience.org/library/papers/39186130PubMed
39085255A tumor targeted nano micelle carrying astragaloside IV for combination treatment of bladder cancer.Sci Rep2024https://conductscience.org/library/papers/39085255PubMed
38844907Programmed death-ligand 1 expression in carcinoma of unknown primary.BMC Cancer2024https://conductscience.org/library/papers/38844907PubMed
38658905
PD-L1 expression in tumor and inflammatory cells is associated with favorable tumor features and favorable prognosis in muscle-invasive urothelial carcinoma of the bladder not treated by immune checkpoint inhibitors.
BMC Urol2024https://conductscience.org/library/papers/38658905PubMed
37877864The Many Faces of Urothelial Carcinomas: An Update From Pathology to Clinical Approach and Challenges in Practice.Urol Res Pract2023https://conductscience.org/library/papers/37877864PubMed
35616216PD-L1 expression and FGFR-mutations among Danish patients diagnosed with metastatic urothelial carcinoma: A retrospective and descriptive study.APMIS2022https://conductscience.org/library/papers/35616216PubMed
35267437Management of Patients with Metastatic Bladder Cancer in the Real-World Setting from the Multidisciplinary Team: Current Opinion of the SOGUG Multidisciplinary Working Group.Cancers (Basel)2022https://conductscience.org/library/papers/35267437PubMed
33909149PD-L1 expression in urothelial bladder cancer varies more among specimen types than between companion assays.Virchows Arch2021https://conductscience.org/library/papers/33909149PubMed
33141317PD-L1 testing in urothelial bladder cancer: essentials of clinical practice.World J Urol2021https://conductscience.org/library/papers/33141317PubMed
32042618PD-L1 testing in urothelial carcinoma: are we there yet?Transl Androl Urol2019https://conductscience.org/library/papers/32042618PubMed
32034486PD-L1 expression in bladder primary in situ urothelial carcinoma: evaluation in BCG-unresponsive patients and BCG responders.Virchows Arch2020https://conductscience.org/library/papers/32034486PubMed
31930091PD-L1 assessment in urothelial carcinoma: a practical approach.Ann Transl Med2019https://conductscience.org/library/papers/31930091PubMed
31586196The Efficacy of Mitotane in Human Primary Adrenocortical Carcinoma Cultures.J Clin Endocrinol Metab2020https://conductscience.org/library/papers/31586196PubMed
31172245[Molecular tumor board-urothelial cancer].Urologe A2019https://conductscience.org/library/papers/31172245PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
CD27429126PubTator's text mininghttps://conductscience.org/library/genes/29126

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/30003574

GET https://conductscience.org/api/papers/v1/30003574/authors